Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY2R | P49146 | 8/20 | 0.73 |
| ▸ | NPY4R | P50391 | 8/20 | 0.73 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.73 |
| ▸ | NPY1R | P25929 | 6/20 | 0.73 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.64 |
| ▸ | GLP1R | P43220 | 3/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30658277 | 0.91 | NPY2R (0.75) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| Dynorphin A (1-17) SCHEMBL30248363 | 0.90 | NPY1R (0.68) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| Dynorphin A (1-17) SCHEMBL31331988 | 0.90 | NPY1R (0.68) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30906368 | 0.90 | NPY2R (0.65) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL31688313 | 0.90 | NPY1R (0.63) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL31182504 | 0.90 | NPY2R (0.73) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL29949399 | 0.90 | NPY2R (0.73) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30906424 | 0.90 | NPY2R (0.70) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30648474 | 0.89 | NPY1R (0.66) | NPY2RNPY4RNPY5RNPY1RCXCR4 | |
| SCHEMBL30824296 | 0.89 | NPY2R (0.74) | NPY2RNPY4RNPY5RNPY1RCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250283037-A1 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2025-09-11 | — | — | US | disclosed |